Last reviewed · How we verify
Metastatic carcinoma to colon
Approved treatments
- Avastin · Washington University School of Medicine
- Bevacizumab · Roche
Bevacizumab binds VEGF and prevents interaction with endothelial cell receptors Flt-1 and KDR. - Avastin · Roche
Bevacizumab works by binding to VEGF-A, preventing it from promoting the growth of new blood vessels that feed tumors.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Metastatic carcinoma to colon patent landscape — cliff calendar, originator estates, attackable patents
- Metastatic carcinoma to colon treatment landscape brief
- Metastatic carcinoma to colon treatment updates RSS
Frequently asked questions about Metastatic carcinoma to colon
What drugs treat Metastatic carcinoma to colon?
Tracked treatments include Avastin, Bevacizumab.
What is the treatment for Metastatic carcinoma to colon?
Standard treatment for Metastatic carcinoma to colon includes Avastin, Bevacizumab. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Metastatic carcinoma to colon patent cliff · Metastatic carcinoma to colon CI report
- Treatment: Avastin · Washington University School of Medicine
- Treatment: Bevacizumab · Roche
- Treatment: Avastin · Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing